CP-2289

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameCP-2289
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor agonistsSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMeiji Seika Kaisha Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMeiji Seika Kaisha Ltd
Active IndicationsN/A
Inactive IndicationsGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A